<DOC>
	<DOCNO>NCT00459914</DOCNO>
	<brief_summary>A small number uncontrolled study show high prevalence sleep apnea patient refractory hypertension CPAP treatment achieve significant reduction blood pressure short term . The purpose study assess prevalence sleep apnea patient refractory hypertension , effect continuous positive pressure treatment systemic blood pressure serum marker endothelial dysfunction angiogenesis .</brief_summary>
	<brief_title>Sleep Apnea Refractory Hypertension : Prevalence Effect CPAP Treatment</brief_title>
	<detailed_description>We assess prevalence apnea hypopnea index ( AHI ) &gt; 5 patient refractory hypertension refer hypertension clinic . Patients AHI &gt; 15 randomize either continue usual pharmacological treatment alone add CPAP usual treatment , 3 month period . The main endpoint comparison mean 24h systolic diastolic blood pressure , assess ambulatory blood pressure monitoring , treatment arm . The secondary endpoint ass change serum marker endothelial dysfunction angiogenesis</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<criteria>Patients refer tertiary hospital hypertension clinic diagnosis refractory hypertension basis office blood pressure high 160/90 mmHg despite recommended dos least 3 drug , include diuretic . Causes secondary hypertension , history alcohol abuse , renal insufficiency , severe chronically illness .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>sleep apnea</keyword>
	<keyword>refractory hypertension</keyword>
	<keyword>continuous positive airway pressure</keyword>
</DOC>